STOCK TITAN

RTW Investments reveals 8.5% Immatics N.V. (IMTX) stake in Schedule 13G/A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

RTW Investments, LP and Roderick Wong, M.D. report beneficial ownership of 11,433,354 ordinary shares of Immatics N.V., representing 8.5% of the company’s outstanding shares. The shares are held by funds advised by RTW Investments, and both RTW and Dr. Wong share voting and dispositive power over them.

The ownership percentage is based on 134,063,829 Immatics ordinary shares outstanding as of December 8, 2025. The filers state the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Immatics.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



RTW Investments, LP
Signature:/s/ Roderick Wong, M.D.
Name/Title:Roderick Wong, M.D., Managing Partner
Date:02/17/2026
Roderick Wong
Signature:s/ Roderick Wong, M.D.
Name/Title:Roderick Wong, M.D.
Date:02/17/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G filed with the SEC on November 14, 2024).

FAQ

What stake in Immatics N.V. (IMTX) does RTW report on this Schedule 13G/A?

RTW Investments, LP and Roderick Wong, M.D. report beneficial ownership of 11,433,354 Immatics ordinary shares, equal to 8.5% of the outstanding class. These shares are held by RTW-managed funds, with shared voting and dispositive power over the position.

How is the 8.5% ownership in Immatics N.V. (IMTX) calculated in this filing?

The 8.5% stake is calculated using 134,063,829 Immatics ordinary shares outstanding as of December 8, 2025, as reported in an Immatics prospectus supplement. RTW’s 11,433,354 shares divided by this total yields the reported ownership percentage.

Who are the reporting persons on the Immatics N.V. (IMTX) Schedule 13G/A?

The reporting persons are RTW Investments, LP, a Delaware investment adviser, and Roderick Wong, M.D., its Managing Partner and Chief Investment Officer. They report beneficial ownership over shares held by certain investment funds they advise.

Do RTW and Roderick Wong control the Immatics N.V. (IMTX) shares directly?

The filing states the shares are directly held by RTW Funds, with RTW Investments and Dr. Wong having shared voting and dispositive power over 11,433,354 shares. It also notes the filing should not be construed as an admission of beneficial ownership for all purposes.

Is the Immatics N.V. (IMTX) stake held for control purposes according to this Schedule 13G/A?

No. The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Immatics, except for activities solely related to nominations under specified proxy rules.

What voting and dispositive powers over Immatics N.V. (IMTX) shares are reported?

RTW Investments and Dr. Wong each report 0 shares with sole voting or dispositive power, and 11,433,354 shares with shared voting and shared dispositive power. This reflects joint authority over how these Immatics shares are voted and potentially sold.
Immatics N.V

NASDAQ:IMTX

IMTX Rankings

IMTX Latest News

IMTX Latest SEC Filings

IMTX Stock Data

1.38B
88.81M
Biotechnology
Healthcare
Link
Germany
Tübingen